According to Ipca Laboratories latest financial reports the cash on hand of IPCALAB is $259.35M, an increase of 60.09% to 2022. At the end of 2022 company had $162.00M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $259.35M | 60.09% |
2022 | $162.00M | 79.33% |
2021 | $90.33M | 81.31% |
2020 | $49.82M | 12.46% |
2019 | $44.30M | - |